Paper Details

  1. Home
  2. Paper Details

Toxicity of targeted therapy in non-small-cell lung cancer management.

Author: RicciardiSerena, TomaoSilverio, de MarinisFilippo

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.

Overview

Targeted therapies, such as EGFR and VEGFR inhibitors, are promising treatments for non-small-cell lung cancer. While these therapies are generally well-tolerated, they can cause dermatologic side effects. Other agents in clinical development are also associated with toxicities.
Paper Details　
Original Abstract of the Article :
Lung cancer is the leading cause of cancer-related death worldwide. Despite several chemotherapeutic agents, a survival plateau has been reached, so new treatment strategies are clearly needed. A strong interest is now focused on the use of targeted therapies for the management of non-small-cell lun...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.3816/CLC.2009.n.004

データ提供：米国国立医学図書館（NLM）

Targeted Therapy for Lung Cancer: Balancing Efficacy and Toxicity

The fight against lung cancer is a challenging journey through the desert of disease. This study explores the use of targeted therapies, a new approach to treating non-small-cell lung cancer (NSCLC). The authors discuss the efficacy and toxicity of these therapies, a delicate balance between hope and potential side effects, like navigating a treacherous landscape with both opportunities and dangers.

Targeted Therapies: A Double-Edged Sword in NSCLC Treatment

The study highlights the benefits of targeted therapies, which offer improved tolerability compared to traditional chemotherapy. This is like finding a more comfortable path through the desert, offering hope for better treatment outcomes. However, the study also acknowledges the potential for dermatologic side effects, a cautionary reminder that even the most promising treatments can come with risks.

Navigating the Risks and Benefits of Targeted Therapy

This research provides valuable insights into the use of targeted therapies for NSCLC. It emphasizes the importance of understanding both the benefits and risks of these treatments, allowing clinicians to make informed decisions for their patients. It’s like a skilled traveler carefully considering the terrain and risks before embarking on a journey through the desert.

Dr. Camel's Conclusion

This research explores the promising landscape of targeted therapies for NSCLC. It highlights the potential benefits of these therapies, offering a more tolerable treatment option, but also acknowledges the potential for side effects. This research provides valuable guidance for navigating the complex terrain of NSCLC treatment, ensuring that patients receive the best possible care.

Date :
  1. Date Completed 2009-04-07
  2. Date Revised 2022-03-18
Further Info :

Pubmed ID

19289369

DOI: Digital Object Identifier

10.3816/CLC.2009.n.004

Related Literature

Article Analysis
・Side Effects of panobinostat
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.